PERSPECTA

News from every angle

← Back to headlines

J&J’s new psoriasis pill to rival AbbVie’s Skyrizi: BNP Paribas

J&J's new psoriasis pill is expected to compete with AbbVie's Skyrizi, according to BNP Paribas.

PostShare

Sources

Showing 0 of 1 sources

Related Stories

FMD cases remain stable as mass culling continues

4m ago

Sharp rise in amphetamine use recorded in Cyprus cities, study finds

8m ago

Επιστήμονες δημιουργούν ανοσοκύτταρα που καταπολεμούν τον καρκίνο απευθείας στο σώμα

9m ago

Παρέμβαση στη Βουλή για τα παιδιά με βαρύ αυτισμό 

10m ago